PDCD1 and non-small cell lung carcinoma: Importantly, our analyses indicate that late-stage NSCLC patients with high expression of PD1 and PDL1, either individually or jointly, tend to suffer a greater risk of recurrence or death than patients with early-stage NSCLC.